A Single Ascending Dose Study of BMS-650032 in HCV Infected Subjects
Status:
Completed
Trial end date:
2008-07-01
Target enrollment:
Participant gender:
Summary
The primary purpose of this study is to evaluate the safety profile and tolerability of
single oral doses of BMS-650032 in subjects with chronic hepatitis C infection